The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses ...
I t was the summer of 2023, and after traveling around the country to promote the latest franchise of my successful workout ...
Abdominal and chest pain. Injuries. Breathing difficulty. Infections. Mental health emergencies. Those are some of the most ...
Neuraxis Inc (NASDAQ:NRIX) stock gained 4.2% in premarket trading Friday after the company received FDA clearance for its nerve stimulation technology to treat functional abdominal pain. The U.S. Food ...
The Manila Times on MSN
100 magnets removed from New Zealand teen's gut
A 13-year-old boy in New Zealand swallowed up to 100 high-power magnets that he bought on Temu, forcing surgeons to remove tissue from his intestines, doctors said on Friday.
A 13-year-old boy in New Zealand swallowed up to 100 high-power magnets he bought on Temu, forcing surgeons to remove tissue ...
A secondary analysis on a randomized trial exploring how tailored cognitive-behavioral therapy affects health care utilization in pediatric functional abdominal pain disorder.
A 13-year-old boy was admitted to hospital after four days of abdominal pain – when he then admitted to doctors that he'd ...
A 13-year-old boy in New Zealand swallowed up to 100 high-power magnets he bought on Temu, forcing surgeons to remove tissue ...
Famed news anchor Christiane Amanpour has announced that her ovarian cancer has returned for a third time. The CNN journalist ...
Achieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged “8 years and older”Expanded age indication will utilize the upcoming January 1st, 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results